Connected healthcare company Truepill raises $25 million

San Mateo-based Truepill announced it closed a $25 million Series B funding round with investments from TI Platform Fund, Optum Ventures, Initialized Capital, Sound Ventures and others. The company has raised a total of $38.4 million since its inception in 2016.

The company acts as a B2B pharmacy fulfillment service, working with health plans, pharmaceutical manufacturers, and consumer health brands alike.

“We are working with our partners to deliver the most innovative healthcare experiences for patients. We are excited to see our API-connected infrastructure being leveraged across the entire healthcare ecosystem. We see a future where over 80% of healthcare visits will be performed using telehealth or a digital experience, and we are positioning Truepill to be the platform building that future.” – Sid Viswanathan, Truepill Co-founder, and President.

According to the company, its pharmacies have the capacity to deliver 100,000 prescriptions per day, and its US-based network of licensed physicians and nurse practitioners can diagnose and prescribe across 50 states. Customers include GoodRx, TherapeuticsMD, K Health, hims & hers, Nurx, and Simple Health.

In addition to growing its B2B business, Truepill will continue to invest in its portfolio of consumer health brands. Truepill-backed companies include Ahead, a modern mental healthcare startup specializing in adult ADHD treatment, and Eve, a UK-based women’s health company.